facebook  twitter  twitter  LinkedIn      

Products:


PureBiotics™ - Research Citations

Bifidobacteriums

Lactis
N. West, P. Horn, D. Pyne, V. Gebski, S. Lahtinen, P. Fricker, A. Cripps, “Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals”, Clinical Nutrition (2013-online), 1-7

Bifidum
KS Hong, HW Kang, JP Im, GE Ji, SG Kim, HC Jung, IS Song, JS Kim, “Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome”, Gut and Liver, 3(2); June, 2009: pp. 101-107

L. Rodes, A. Khan, et al, “Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model”, Journal of Microbiology & Biotechnology, (2013), 23(4), 518-526

Infantis
L. O’Mahony, J. McCarthy, P. Kelly, et al, “Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome: Symptom Responses and Relationship to Cytokine Profiles”, Gastroenterology 2005; 128: 541-551

EM Fernandez, B. Pot, and C. Grangette, “Beneficial effect of probiotics in IBD: Are peptidogycan and NOD2 the molecular key effectors?”, Gut Microbes, 2:5,280-286, September/October 2011

L. Rodes, A. Khan, et al, “Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model”, Journal of Microbiology & Biotechnology, (2013), 23(4), 518-526

Breve
SG Jeon, H. Kayama, Y. Ueda, et al, “Probiotic Bifidobacterium breve Induces IL-10-Producting Tr1 Cells in the Colon”, PLoS Pathogens (online) May, 2012; 8(5): 1-15

Longum
L. Rodes, A. Khan, et al, “Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model”, Journal of Microbiology & Biotechnology, (2013), 23(4), 518-526

Lactobacillus

Acidophilus
N. West, P. Horn, D. Pyne, V. Gebski, S. Lahtinen, P. Fricker, A. Cripps, “Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals”, Clinical Nutrition (2013-online), 1-7

KS Hong, HW Kang, JP Im, GE Ji, SG Kim, HC Jung, IS Song, JS Kim, “Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome”, Gut and Liver, 3(2); June, 2009: pp. 101-107

S. Todorov, D. Furtado, et al, “Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus LA-14, a potential probiotic strain”. New Microbiologica, 34; 357-370, 2011

EM Fernandez, B. Pot, and C. Grangette, “Beneficial effect of probiotics in IBD: Are peptidogycan and NOD2 the molecular key effectors?”, Gut Microbes, 2:5,280-286, September/October 2011

ZJ Wu, X. Du, J. Zheng, “Role of Lactobacillus in the prevention of clostridium difficile-associated diarrhea: a meta-analysis of randomized controlled trials” Chin Med J 2013; 126 (21): 4154-4161

Salivarius
L. O’Mahony, J. McCarthy, P. Kelly, et al, “Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome: Symptom Responses and Relationship to Cytokine Profiles”, Gastroenterology 2005; 128: 541-551

EM Fernandez, B. Pot, and C. Grangette, “Beneficial effect of probiotics in IBD: Are peptidogycan and NOD2 the molecular key effectors?”, Gut Microbes, 2:5,280-286, September/October 2011

N. Larsen, F. Vogensen, et al, “Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents” Clinical Nutrition 32(2013); 935-940

Plantarum
EM Fernandez, B. Pot, and C. Grangette, “Beneficial effect of probiotics in IBD: Are peptidogycan and NOD2 the molecular key effectors?”, Gut Microbes, 2:5,280-286, September/October 2011

L. Rodes, A. Khan, et al, “Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model”, Journal of Microbiology & Biotechnology, (2013), 23(4), 518-526

Rhamnosus
L. Rodes, A. Khan, et al, “Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model”, Journal of Microbiology & Biotechnology, (2013), 23(4), 518-526

Paracasei
C. Holz, C. Alexander, C. Balcke, et al, “Lactobacillus papacasei DSMZ16671 Reduces Mutans Streptococci: A Short-Term Pilot Study”, Probiotics & Antimicrobial Prot. (2013) 5:259-263

Brevis
G. Campus, F. Cocco, G. Carta, et al, “Effect of a daily dose of lactobacillus breve CD2 lozenges in high caries risk school children”, Clinical Oral Investigation (2014) 18:555-561

Bulgaricus
T. Takamura, D. Harama, S. Fukumoto, et al, “Lactobacillus bulgaricus OLL181 activates the aryl hydrocarbon receptor pathway and inhibits colitis”, Immunology & Cell Biology (2011) 89, 817-822

Gasseri
R. Deguchi, H. Nakaminami, E. Rimbara, et al, “Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy”, Journal of Gastroenterology & Hepatology, 27 (2102); 888-892                                

Casei
ZJ Wu, X. Du, J. Zheng, “Role of Lactobacillus in the prevention of clostridium difficile-associated diarrhea: a meta-analysis of randomized controlled trials” Chin Med J 2013; 126 (21): 4154-4161

Lactis
T. Karpinski and AK Szaradkiewicz, “Characteristic of Bacteriocines and their Application”,  Polish Journal of Microbiology 2013, Vol. 62, No. 3, 223-235


 

Pure Essence Labs - Home Page